Metformin-associated lactic acidosis (MALA) has estimated the incidence of 3--9/100,000 patient-years\[[@ref1]\] and mortality rate ranging from 9.1% to 61% with inconsistent prognostic factors\[[@ref1][@ref2][@ref3]\] \[[Table 1](#T1){ref-type="table"}\].

###### 

Summary of major cohorts in metformin-associated lactic acidosis
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Patients admitted to Intensive Care Unit (ICU) of Queen Elizabeth Hospital in Hong Kong between January 2011 and December 2015 were included in the retrospective study if they met the following criteria: (1) metformin as usual treatment or overdose; (2) peak lactate \>5 mmol/L; (3) pH \<7.35 and bicarbonate \<22 mmol/L. Patients were excluded if they were admitted for (1) postcardiac arrest or (2) postoperative care or (3) conditions other than MALA in which investigators identify as the main cause of lactic acidosis. This study was performed in compliance with ethical standard of the Helsinki declaration and approved by the research ethics committee.

Eighty-four patients with elevated lactate level had taken metformin as usual medication or overdose. Twenty-five patients were excluded due to postcardiac arrest (*n* = 4), postoperative care (*n* = 15), extracorporeal membrane oxygenation therapy (*n* = 4), nonacidemia (*n* = 1), and massive ST-elevation myocardial infarction (*n* = 1).

The baseline characteristics of the eligible patients were summarized in [Table 2](#T2){ref-type="table"}.

###### 

Patient baseline characteristics, precipitating factors, and outcome

![](IJCCM-21-875-g002)

Compared with the 54 survivors, the 5 nonsurvivors had higher Acute Physiology and Chronic Health Evaluation IV (APACHE IV) scores (*P* = 0.005), APACHE IV predicted mortality risk (*P* = 0.003), temperature (*P* = 0.032), heart rate (*P* = 0.035), and PaCO~2~ (*P* = 0.002); and lower first 24-h urine volume (*P* = 0.013) and serum albumin (*P* = 0.012). They were more likely to be on mechanical ventilation (*P* = 0.014) and suffer from sepsis (*P* = 0.001). They had higher maximum dosages of noradrenaline infusion (*P* = 0.009) and longer median time from hospital admission to commencement of renal replacement therapy (RRT).

The receiver operating characteristics curve for the time from admission to RRT with the outcome of mortality had an area under curve of 0.776 (*P* = 0.043). Sensitivity and specificity would both be 80% if the cutoff was set at 765.5 min from admission to RRT \[[Figure 1](#F1){ref-type="fig"}\].
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When comparing patients with other precipitating factors, patients with sepsis were found to have higher heart rates (*P* = 0.016), PaCO~2~ levels (*P* = 0.017), APACHE IV risk (*P* = 0.02), sequential organ failure assessment score (*P* = 0.001), and maximum nor-adrenaline infusion dosages (*P* = 0.001), with higher rates of mechanical ventilation (*P* = 0.013) and ICU mortality (*P* = 0.001).

Patients with intentional self-inflicted overdose had higher pH (*P* = 0.009) and bicarbonate (*P* \< 0.001); and lower serum creatinine level (*P* \< 0.001), APACHE IV predicted mortality risk (*P* = 0.02), maximum noradrenaline infusion dosages (*P* = 0.043), and rate of RRT (*P* \< 0.001). None of the patients died in the ICU but there is no significant difference in ICU mortality.

Septic patients and patients with higher serum creatinine level had a longer duration of RRT dependence \[Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}; *P* = 0.026 and 0.005, respectively\].
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RRT would be theoretically beneficial in MALA by the elimination of metformin and lactate, correction of acidosis and electrolyte abnormalities and as a support for impaired kidney function. Our study is the first study to demonstrate a longer time from hospital admission to RRT in nonsurvivors, suggesting a beneficial effect of early RRT. The benefits of early RRT in critically ill patients have been debated. In 2016, there were two randomized controlled trials published on early versus late RRT in critically ill patients with different results.\[[@ref4][@ref5]\]
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